The Thai Medical Services Department signed an agreement with Pfizer (Thailand) today (Thursday) to procure 50,000 courses (2 million tablets) of the Paxlovid anti-viral medicine for the treatment of COVID-19.

 

The delivery of the drug is expected in mid-April.

 

Director-General of the department Dr. Somsak Akksilp said that the oral medication can reduce the risk of hospitalisation and death in severe COVID-19 cases by about 88%, if administered within five days of first symptoms being detected, according to clinical trials. This was high enough for the US National Institutes of Health to prioritise the drug over other treatments.

 

Keep up to date with all things Thailand - Join our daily ASEAN NOW Thailand Newsletter - Click to subscribe

 

Full Story: https://www.thaipbsworld.com/thailand-signs-deal-with-pfizer-to-supply-2-million-anti-viral-paxlovid-tablets/

 

-- © Copyright Thai PBS 2022-03-24

 

- Aetna offers a range of visa-compliant plans that meet the minimum requirement of medical treatment, including COVID-19, up to THB 3m. For more information on all expat health insurance plans click here.

 

- Follow ASEAN NOW on LINE for breaking COVID-19 updates

 

Pfizer’s Paxlovid, part of the White House’s ‘test and treat’ plan, cannot be taken by those on certain antidepressants, anti-seizure, anti-psychotic, cholesterol, blood pressure and several other classes of medications.